Sequential expression of chemokines in experimental autoimmune neuritis

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 121-129

  Kieseier, Bernd C ^a   Krivacic, Kim ^b   Jung, Stefan ^c   Pischel, Heidrun ^a   Toyka, Klaus V ^c   Ransohoff, Richard M ^b   Hartung, Hans Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chemokine; Demyelination; Experimental autoimmune neuritis; Guillain Barre syndrome; Inflammation; Peripheral nerve

Indexed keywords

CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENDOTHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEURITIS; NONHUMAN; PATHOGENESIS; PERINEURIUM; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; T LYMPHOCYTE;

ANIMAL; CHEMOKINES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; GENE EXPRESSION; GUILLAIN-BARRE SYNDROME; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NEURITIS; PYRIMIDINONES; RANTES; RATS; RATS, INBRED LEW; RNA, MESSENGER; SCIATIC NERVE; SUPPORT, NON-U.S. GOV'T;

EID: 0034597087     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00323-4     Document Type: Article

References (45)

1. Archelos J.J., Previtali S.C., Hartung H.-P. The role of integrins in immune-mediated diseases of the nervous system. Trends Neurosci. 22:1999;30-38.
2. Ari H., Charo I.F. Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 271:1996;21814-21819.
3. Arnason B.G.W., Soliven B. Dyck P.J., Thomas P.K., Griffin J.W., Low P.A., Poduslo J. Peripheral Neuropathy. Vol. 3:1993;1437-1497 Saunders, Philadelphia, PA.
4. Bacon K.B., Premack B.A., Gardner P., Schall T.J. Activation of dual T cell signaling pathways by the chemokine RANTES. Science. 269:1995;1727-1730.
5. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
6. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:1994;97-179.
7. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15:1997;675-705.
8. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1a and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA. 96:1999;6873-6878.
9. Bolin L.M., Murray R., Lukacs N.W., Strieter R.M., Kunkel S.L., Schall T.J., Bacon K.B. Primary sensory neurons migrate in response to the chemokines RANTES. J. Neuroimmunol. 81:1998;49-57.
10. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
11. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., Butcher E.C. Chemokines and arrest of lymphocytes rolling under flow conditions. Science. 279:1998;381-384.
12. Charles P.C., Chen X., Horwitz M.S., Brosnan C.F. Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J. Neurovirol. 5:1999;55-64.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Cornblath D.R., Griffin D.E., Welch D., Griffin J.W., McArthur J.C. Quantitative analysis of endoneurial T cells in human sural nerve biopsies. J. Neuroimmunol. 26:1990;113-118.
15. Fujioka T., Purev E., Rostami A. Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. J. Neuroimmunol. 97:1999;51-59.
16. Glabinski A., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.
17. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
18. Gu L., Tseng S., Horner R.M., Tam C., Loda M. Rollins, B.J., 2000. Control of Th2 polarization by the chemokine, monocyte chemoattractant protein-1. Nature. 404:2000;407-411.
19. Hartung H.-P., Pollard J.D., Harvey G.K., Toyka K.V. Invited review: immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I and II. Muscle Nerve. 18:1995;137-164.
20. Hartung H.-P., Toyka K.V., Griffin J.W. Antel J., Birnbaum G., Hartung H.-P. Clinical Neuroimmunology. 1998;294-306 Blackwell Science, Malden, USA.
21. Hughes R.A.C. The Guillain-Barré Syndrome. 1990;Springer, London.
22. Hulkower K., Brosnan C.F., Aquino D.A., Cammer W., Kulshrestha S., Guida M.P., Rapoport D.A., Berman J.W. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental autoimmune encephalomyelitis. J. Immunol. 150:1993;2525-2533.
23. Jung S., Toyka K.V., Hartung H.-P. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats. Neurosci. Lett. 200:1995;167-170.
24. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encepahlomyelitis. J. Immunol. 155:1995;5003-5010.
25. Kieseier B.C., Clements J.M., Pischel H.B., Wells G.M.A., Miller K., Gearing A.J.H., Hartung H.-P. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré Syndrome. Ann. Neurol. 43:1998;427-434.
26. Lindhout E., Visser J.L.M., Figdor C.G., Adema G.J. Chemokines and lymphocyte migration. Immunologist. 7:1999;147-152.
27. Lindley I., Westwick J., Kunkel S. Nomenclature announcement: the chemokines. Immunol. Today. 14:1993;24.
28. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:1996;963-969.
29. Lu B., Humbles A., Bota D., Gerard C., Moser B., Soler D., Luster A.D., Gerard N.P. Structure and function of the murine chemokine receptor CXCR3. Eur. J. Immunol. 29:1999;3804-3812.
30. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:1998;436-445.
31. McTigue D., Tani M., Kravacic K., Chernosky A., Kelner G., Maciejewski D., Maki R., Ransohoff R., Stokes B. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J. Neurosci. Res. 53:1998;368-376.
32. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593-633.
33. Polydefkis M.J., Krivacic K., Tani M., Ransohoff R.M., Griffin J.W., Ho T.W. Rat Schwann cells upregulate MCP-1 synthesis in response to TNF alpha and IFN gamma. Neurology. 50:1998;A184.
34. Ransohoff R.M. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98:1999;57-68.
35. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., Estes M.L., Thomas D.M., Tuohy V.K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:1993;592-600.
36. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
37. Schmidt B., Toyka K.V., Kiefer R., Full J., Hartung H.-P., Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 19:1996;474-487.
38. Sørensen T.L., Tani M., Jemsem J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815.
39. Strunk T., Bubel S., Mascher B., Schlenke P., Kirchner H., Wandinger K.-P. Increased numbers of CCR5+ interferon-γ- and tumor necrosis factor-α-secreting T lymphocytes in multiple sclerosis patients. Ann. Neurol. 47:2000;269-273.
40. Tani M., Glabinski A.R., Tuohy V.K., Stoler M.H., Estes M.L., Ransohoff R.M. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 148:1996;889-896.
41. Toews A.D., Barret C., Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J. Neurosci. Res. 53:1998;260-267.
42. Toyka K.V. Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatments. Rev. Neurol. (Paris). 155:1999;849-856.
43. Waksman N.H., Adams R.D. Allergic neuritis: an experimental disease in rabbits induced by the injection of peripheral nervous tissue and adjuvant. J. Exp. Med. 102:1955;213-225.
44. Youssef S., Wildbaum G., Maor G., Lanir N., Gour-Lavie A., Grabie N., Karin N. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J. Immunol. 161:1998;3870-3879.
45. Zou L.P., Pelidou S.H., Abbas N., Deretzi G., Mix E., Schaltzbeerg M., Winblad B., Zhu J. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol. 98:1999;168-175.